menu search

Mtum: just doesn't live up to the momentum hype

iShares MSCI USA Momentum Factor ETF has not demonstrated much momentum despite its name. The MTUM exchange-traded fund holds 123 individual stocks, w...

November 3, 2023, 1:06 pm

Eli lilly beats on q3 earnings: etfs to buy

Eli lilly (LLY) posted robust third-quarter 2023 earnings results, beating estimates on both the top an...

November 3, 2023, 12:47 pm

Ozempic sales soar 56% in q3. but is eli lilly a better stock to buy than novo nordisk?

Novo Nordisk delivered sizzling Q3 growth, thanks mainly to soaring sales for Ozempic. However, Eli Lilly's Q3 results looked even better than Novo No...

November 3, 2023, 5:51 am

Three-stock lunch: eli lilly, doordash and target

Eva Ados, ERShares CIO, joins 'Power Lunch' to discuss three stocks: Eli Lilly, DoorDash and Target....

November 2, 2023, 3:31 pm

Expect eli lilly's momentum to continue, says bank of america's geoff meacham

Geoff Meacham, Bank of America senior pharmaceutical analyst, joins 'The Exchange' to discuss Eli Lilly's performance, the demand outlook for weight l...

November 2, 2023, 2:40 pm

Compared to estimates, lilly (lly) q3 earnings: a look at key metrics

While the top- and bottom-line numbers for lilly (LLY) give a sense of how the business performed in th...

November 2, 2023, 12:02 pm

Novo nordisk, eli lilly stocks see boost on obesity drugs

Novo Nordisk (NVO) shares rose as the drugmaker's third-quarter profits jumped 56% year-over-year, fueled by surging demand for its obesity drugs Ozem...

November 2, 2023, 11:26 am

Why eli lilly stock is jumping today

Lilly's Q3 revenue soared, but its earnings sank. However, the company's top- and bottom-line results handily beat Wall Street estimates....

November 2, 2023, 10:59 am

Eli lilly results top estimates on mounjaro strength but slashes full-year profit outlook

CNBC's Joe Kernen reports on the company's quarterly earnings results....

November 2, 2023, 8:10 am

Eli lilly stock falls as earnings guidance slashed dramatically

lilly slashes its guidance for full-year earnings to a range of $6.50 to $6.70 a share, having raised i...

November 2, 2023, 6:54 am

Eli lilly's stock drops after surprise profit is reported but full-year outlook was slashed

Shares of Eli lilly & Co. LLY, +0.10% dropped 1.8% in premarket trading Thursday, after the drug giant ...

November 2, 2023, 6:51 am

Eli lilly beats quarterly revenue estimates on mounjaro strength

Eli lilly beat Wall Street's revenue estimates for the third quarter on Thursday, lifted by strong dema...

November 2, 2023, 6:36 am

Zimvie inc. (zimv) q3 2023 earnings call transcript

ZimVie Inc. (NASDAQ:ZIMV ) Q3 2023 Earnings Conference Call November 1, 2023 4:30 PM ET Company Participants Marissa Bych - Investor Relations, Gilmar...

November 1, 2023, 9:57 pm

Curious about lilly (lly) q3 performance? explore wall street estimates for key metrics

Evaluate the expected performance of lilly (LLY) for the quarter ended September 2023, looking beyond t...

November 1, 2023, 10:34 am

Why beam and verve therapeutics shares soared while eli lilly soured today

The trio was involved in a deal for gene-editing programs. The arrangement is potentially worth $600 million....

October 31, 2023, 7:09 pm

Verve stock soars on $250 million eli lilly deal

lilly will pay $250 million to Beam for the rights to three gene-editing drugs from Verve. VERV stock a...

October 31, 2023, 1:54 pm

Eli lilly stock has quadrupled in 3 years. could a weight-loss drug approval make it happen again?

Speculation and hype created the bulk of Eli Lilly's bullishness of late rather than plausible fundamentals. The rampant speculation around Mounjaro l...

October 31, 2023, 10:12 am

Verve and lilly relationship expands to include verve’s in vivo gene editing programs targeting pcsk9 and angptl3

lilly Purchases Product Rights to Verve’s Lead Cardiovascular Programs from Beam Therapeutics BOSTON,...

October 31, 2023, 10:01 am

Beam therapeutics up 10% on $600m lilly deal

Shares in Beam Therapeutics Inc were up 10% premarket following a deal to sell rights to a licensing deal with Verve Therapeutics to Eli ...

October 31, 2023, 8:37 am

Pph: a 'shot in the arm' for investors looking to capitalize on recent pharmaceutical advances

VanEck Pharmaceutical ETF has had the strongest one-year performance of four major pharmaceutical ETF competitors due to its unique mix of Novo Nordis...

October 31, 2023, 3:35 am


Search within

Pages Search Results: